Keywords : Medical Equipment
Oppenheimer & Co. Inc. - Medical Equipment - Advisory Profile Summary Oppenheimer & Co. Inc. is an investment bank and firm. It provides financial services and advice to high net worth investors, individuals, businesses and institutions. GlobalData’s Oppenheimer & Co. Inc. - Medical Equipment - Advisory Profile provides an overview of the deals advised by Oppenheimer & Co. Inc. in the Medical Equipment market. The re...
More »
Search ReportLinker
The Largest Collection of Market Research Reports
» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides
From +200,000 authoritative sources
Oppenheimer & Co. Inc. - Medical Equipment - Advisory Profile
Summary
Oppenheimer & Co. Inc. is an investment bank and firm. It provides financial services and advice to high net worth investors, individuals, businesses and institutions.
GlobalData’s Oppenheimer & Co. Inc. - Medical Equipment - Advisory Profile provides an overview of the deals advised by Oppenheimer & Co. Inc. in the Medical Equipment market. The report is an essential source of information for Medical Equipment companies, which require the services of financial/legal advisors in their area/region for raising capital or acquiring a company. The report summarizes Oppenheimer & Co. Inc.'s deals for the past five years segregated into year, deal type, segment and geography.
Scope
- Provides essential information on the financial deals in which the firm provided financial/legal advisory services. The deals include mergers and acquisitions, asset financing, asset transactions, private equity / venture capital deals, equity offerings, debt offerings, partnerships, and licensing agreements
- Outlines key advisor information for business intelligence needs such as name, business overview, location and contact information
- Analyzes the advisor’s deals by year, deal type, segment and geography
- Provides detailed information on deal particulars, including information about other advisors involved in the deal
- Includes information on the role played by the advisor in specific deals, and the extent of fees/commission charged by the advisor in a particular transaction, if disclosed
- Consists of Deals Advised by Year chart and table displaying information on the number of deals and value reported by the advisor by year, for a five year period
- Incorporates information on the major recent financial deals of the advisor. Each such deal carries a Summary, deal type, deal rationale, deal financials and target company’s key financial metrics and ratios (financials are available for major public companies)
Reasons to Buy
- Receive detailed information and evaluate the profile of a particular advisor in the market before considering for your business needs
- Peruse all the advisor’s deals in the Industry market
- Access detailed information about the advisor’s financial deals for the past five years that enable you to scrutinize the key deals, which have shaped investment policies
- Identify other potential advisors currently active in your industry, or industry that you wish to foray into
- Compare your advisory services vis-à-vis your competitors’
- Check and identify the advisor that suits your requirements, such as placement agents, book-runners and underwriters
- Examine the breakdown of deals by category and detailed information on major deals incorporated in the advisor’s profile for your academic or business research needs and their suitability to your requirements.
Medical Equipment And Supply Industry in the United States
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Oppenheimer & Co. Inc., Medical Equipment Deals Advised By Year, 2006 to YTD 2012 6
Oppenheimer & Co. Inc., Medical Equipment Deals Advised By Type, 2006 to YTD 2012 7
Oppenheimer & Co. Inc., Medical Equipment Deals Advised By Region, 2006 to YTD 2012 8
Oppenheimer & Co. Inc., Medical Equipment Deals Advised By Market, 2006 to YTD 2012 9
Oppenheimer & Co. Inc., Medical Equipment Deals Advised Summary, 2006 to YTD 2012 10
Oppenheimer & Co. Inc., Medical Equipment, Deal Details 14
Acquisition 14
Integra LifeSciences Acquires SeaSpine 14
LabCorp Completes Acquisition Of Orchid Cellmark For $85 Million 16
Hanger Orthopedic Completes Acquisition Of Accelerated Care Plus 19
HealthTronics Completes Acquisition Of Endocare 21
Inverness Medical Innovations Acquires Matritech 23
Equity Offerings 24
Vermillion Completes Private Placement Of $20.6 Million 24
BioForm Medical Completes IPO Of $92 Million 26
Antares Pharma Completes Private Placement Of $16 Million 27
STARLIMS Technologies Completes Public Offering Of $30.05 Million 29
Cardium Therapeutics Completes Private Placement Of $21.5 Million 31
Rosetta Genomics Completes IPO For $30 Million 33
MannKind Completes Public Offering Of $400 Million 35
AKELA Pharma Completes IPO Of $28.13 Million 37
MINRAD INTERNATIONAL Completes Public Offering Of $37.38 Million 39
Emdeon Completes IPO Of $166.24 Million 41
SEQUENOM Completes Public Offering Of $98.04 Million 43
Derma Sciences Completes Private Placement Of $6.1 Million 45
AspenBio Pharma Completes Private Placement Of $18 Million 47
North American Scientific Completes Private Placement Of $15.5 Million 49
Derma Sciences Completes Private Placement Of $6 Million 51
SEQUENOM Completes Private Placement of $30.45 Million 53
Zogenix Completes Underwriters Over-Allotment Option Of IPO For $57.7 Million 55
Uroplasty Completes Underwritten Public Offering Of Common Stock For $16.1 Million 57
Aeroflex Holding Completes IPO Of $267 Million 59
Aastrom Biosciences Completes Underwritten Public Offering Of $14 Million 61
Microvision Completes Public Offering Of Common Stock For $9.9 Million 63
Alimera Sciences Completes IPO For $72 Million 65
Stereotaxis Completes Public Offering Of $30 Million 67
Kraton Performance Polymers Completes IPO For $139 Million 69
SXC Health Solutions Completes Public Offering For $214.76 Million 71
Seattle Genetics Completes Public Offering Of $136 Million 73
Antares Pharma Completes Private Placement Of Units For $8.5 Million 75
Electro-Optical Sciences Completes Registered Direct Offering Of $15 Million 77
Stereotaxis Completes Underwritten Public Offering Of $16.79 Million 79
Sequenom Completes Public Offering Of Common Stock For $62 Million 81
Microvision Completes Public Offering Of Units For $10.5 Million 83
Zogenix Completes Public Offering Of Common Stock For $61.4 Million 85
Derma Sciences Completes Private Placement For $29 Million 87
Derma Sciences Completes Private Placement Of $6.37 Million 89
SEQUENOM Completes Private Placement Of $33 Million 91
Omrix Biopharmaceuticals Completes IPO Of $39.53 Million 93
Debt Offerings 95
Integra LifeSciences Holdings Completes Private Placement Of Convertible Senior Notes Due 2016 For $230 Million 95
Hanger Orthopedic Completes Private Placement Of Senior Notes Due 2018 For $200 Million 97
Asset Transactions 99
Sorin Acquires Cannulae Product Line From ESTECH 99
Derma Sciences Acquires Assets Of Western Medical 100
Appendix 101
Methodology 101
About GlobalData 101
Contact Us 101
Disclaimer 101
List of Tables
Oppenheimer & Co. Inc., Key Facts 1
Oppenheimer & Co. Inc., Medical Equipment Deals Advised Summary, 2006 to YTD 2012 1
Oppenheimer & Co. Inc., Medical Equipment Deals Advised By Year, 2006 to YTD 2012 6
Oppenheimer & Co. Inc., Medical Equipment Deals Advised By Type, 2006 to YTD 2012 7
Oppenheimer & Co. Inc., Medical Equipment Deals Advised By Region, 2006 to YTD 2012 8
Oppenheimer & Co. Inc. Deals Advised By Market, 2006 to YTD 2012 9
Oppenheimer & Co. Inc., Medical Equipment Deals Advised Summary, 2006 to YTD 2012 10
Integra LifeSciences Acquires SeaSpine 14
LabCorp Completes Acquisition Of Orchid Cellmark For $85 Million 16
Hanger Orthopedic Completes Acquisition Of Accelerated Care Plus 19
HealthTronics Completes Acquisition Of Endocare 21
Inverness Medical Innovations Acquires Matritech 23
Vermillion Completes Private Placement Of $20.6 Million 24
BioForm Medical Completes IPO Of $92 Million 26
Antares Pharma Completes Private Placement Of $16 Million 27
STARLIMS Technologies Completes Public Offering Of $30.05 Million 29
Cardium Therapeutics Completes Private Placement Of $21.5 Million 31
Rosetta Genomics Completes IPO For $30 Million 33
MannKind Completes Public Offering Of $400 Million 35
AKELA Pharma Completes IPO Of $28.13 Million 37
MINRAD INTERNATIONAL Completes Public Offering Of $37.38 Million 39
Emdeon Completes IPO Of $166.24 Million 41
SEQUENOM Completes Public Offering Of $98.04 Million 43
Derma Sciences Completes Private Placement Of $6.1 Million 45
AspenBio Pharma Completes Private Placement Of $18 Million 47
North American Scientific Completes Private Placement Of $15.5 Million 49
Derma Sciences Completes Private Placement Of $6 Million 51
SEQUENOM Completes Private Placement of $30.45 Million 53
Zogenix Completes Underwriters Over-Allotment Option Of IPO For $57.7 Million 55
Uroplasty Completes Underwritten Public Offering Of Common Stock For $16.1 Million 57
Aeroflex Holding Completes IPO Of $267 Million 59
Aastrom Biosciences Completes Underwritten Public Offering Of $14 Million 61
Microvision Completes Public Offering Of Common Stock For $9.9 Million 63
Alimera Sciences Completes IPO For $72 Million 65
Stereotaxis Completes Public Offering Of $30 Million 67
Kraton Performance Polymers Completes IPO For $139 Million 69
SXC Health Solutions Completes Public Offering For $214.76 Million 71
Seattle Genetics Completes Public Offering Of $136 Million 73
Antares Pharma Completes Private Placement Of Units For $8.5 Million 75
Electro-Optical Sciences Completes Registered Direct Offering Of $15 Million 77
Stereotaxis Completes Underwritten Public Offering Of $16.79 Million 79
Sequenom Completes Public Offering Of Common Stock For $62 Million 81
Microvision Completes Public Offering Of Units For $10.5 Million 83
Zogenix Completes Public Offering Of Common Stock For $61.4 Million 85
Derma Sciences Completes Private Placement For $29 Million 87
Derma Sciences Completes Private Placement Of $6.37 Million 89
SEQUENOM Completes Private Placement Of $33 Million 91
Omrix Biopharmaceuticals Completes IPO Of $39.53 Million 93
Integra LifeSciences Holdings Completes Private Placement Of Convertible Senior Notes Due 2016 For $230 Million 95
Hanger Orthopedic Completes Private Placement Of Senior Notes Due 2018 For $200 Million 97
Sorin Acquires Cannulae Product Line From ESTECH 99
Derma Sciences Acquires Assets Of Western Medical 100
List of Figures
Oppenheimer & Co. Inc., Medical Equipment Deals Advised by Deal Type, 2006 to YTD 2012 1
Oppenheimer & Co. Inc., Medical Equipment Deals Advised By Year, 2006 to YTD 2012 1
Oppenheimer & Co. Inc., Medical Equipment Deals Advised By Region, 2006 to YTD 2012 1
Oppenheimer & Co. Inc., Medical Equipment Deals Advised By Market, 2006 to YTD 2012 1
Oppenheimer & Co. Inc., Medical Equipment Deals Advised By Year, 2006 to YTD 2012 6
Oppenheimer & Co. Inc., Medical Equipment Deals Advised by Deal Type, 2006 to YTD 2012 7
Oppenheimer & Co. Inc., Medical Equipment Deals Advised By Region, 2006 to YTD 2012 8
Oppenheimer & Co. Inc., Medical Equipment Deals Advised by Market, 2006 to YTD 2012 9
